What Bio Med Sciences does

Bio Med Sciences, Inc. is a specialty medical device and skin-care company founded in 1987 by Mark Dillon in Allentown, Pennsylvania, based on his senior thesis at Alfred University developing a polymer that combined silicone and Teflon (PTFE). The company's core technology is Silon-IPN, an Interpenetrating Polymer Network protected by over 60 patents, which delivers the softness and tack of silicone with the physical strength of PTFE and is configurable in 10-750 micron thicknesses for semipermeable membranes. This platform underpins three product categories: advanced wound care (Silon-TSR, Dual-Dress 50, Rylon-1, exsalt T7) used in burn centers, dermatology, and plastic surgery; scar management products (Oleeva Fabric, Oleeva Foam, Oleeva Scar Shapes, Oleeva Clear, Silon-LTS, Silon-STS, Silon-TEX II, Silon Gel Cleanser) for hypertrophic scars and keloids; and renewing technologies such as SeaAllure, a nighttime skin-firming patch for the consumer anti-aging market. The company also distributes Suprathel, an absorbable skin substitute, in the United States.

Bio Med Sciences operates a hybrid go-to-market model. Professional wound care and scar management products are sold directly to burn centers, plastic surgeons, dermatologists, and rehabilitation specialists, supported by clinical publications and conference participation (American Burn Association, European Burns Association). Consumer products (Oleeva, SeaAllure) are sold direct-to-consumer via company e-commerce platforms, and the company also serves as an authorized distributor network and offers contract R&D and custom manufacturing services for medical device manufacturers. Revenue streams include one-time product sales, licensing and royalty income (notably from Pfizer for Neosporin Scar Solution retail distribution), and partnership-derived revenue (Dr. Denese HydroShield eye patches through QVC). Products reach over 35 countries through direct sales, e-commerce, and regional distributors such as Therapist Support Laboratory in Australia.

In May 2024, Bio Med Sciences was acquired by Wacker Chemie AG, a Germany-based chemical manufacturing company, ending 37 years of independent founder ownership. At the time of acquisition, the company operated from a 2021-relocated facility adjacent to Lehigh Valley International Airport that tripled its prior space and more than doubled production capacity, was FDA-registered and ISO-compliant, and held OEKO-TEX Standard 100 certification for its Silon-TEX II textile insert.

Name

Bio Med Sciences

Legal name

Bio Med Sciences, Inc.

Website

https://silon.com

Company type

Private

Founded year

1987

Operating status

Acquired

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Medical Wound Care Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Wound Care & Ulcer Management (HLAKACAN)

akta.pro secondary industries

Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE), Wound & Ostomy Skin Care (Barrier Films/Creams, Adhesive Removers, Cleansers) (HLAHALAK), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Medical wound care
• Scar management
• Silicone polymer technology
• Skin renewing products
• Burn treatment dressings

Headquarters

HQ city

Allentown

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Direct Product Sales: Sale of wound care, scar management, and skin renewing products directly to consumers via e-commerce platforms and to healthcare providers through professional channels.
2. Technology Licensing - Pfizer/Neosporin: Licensed Silon technology to Pfizer for consumer retail market under Neosporin Scar Solution brand. Bio Med continues to supply professional market while Pfizer handles retail distribution.
3. Partnership Products - Dr. Denese: Partnership combining Silon technology with HydroShield for eye patch products sold through QVC.
4. Distribution Sales: Products available exclusively from Bio Med and authorized distributors. Includes international distribution through partners like Therapist Support Laboratory in Australia.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Bio Med Sciences designs, develops, and manufactures medical wound care dressings, scar management products, and skin renewing technologies built on its proprietary Silon-IPN polymer technology that combines silicone and PTFE. The company sells advanced wound care dressings (Silon-TSR, Dual-Dress 50, exsalt T7, Rylon-1) to professional healthcare providers, scar management solutions (Oleeva line, Silon-TEX II) to both providers and consumers, and anti-aging products (SeaAllure) directly to consumers. It also distributes Suprathel skin substitute in the U.S. and offers contract R&D and custom manufacturing services.

Product overview

Bio Med Sciences offers a portfolio of medical products centered on its proprietary Silon technology (an interpenetrating polymer network combining silicone and PTFE). The product lines include: Advanced Wound Care products (exsalt T7, Rylon-1, Silon-TSR, Dual-Dress 50) for burn treatment and wound management; Scar Management products (Oleeva Fabric/Foam/Scar Shapes/Clear, Silon-LTS, Silon-STS, Silon-TEX II, Silon Gel Cleanser) for hypertrophic scar and keloid treatment; and Renewing Technologies (SeaAllure) for anti-aging skin care. The company also distributes Suprathel (an alloplastic skin substitute). Products are sold to professional healthcare providers, consumers, and through distributors worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Silon®: Patented silicone technology platform combining silicone and PTFE for wound care, scar management, and skin care products.
• Oleeva®
• SeaAllure™

Products and services

• exsalt T7 Advanced wound care dressing designed for professional healthcare providers treating burn injuries, dermatology, cosmetic surgery, long-term care, and rehabilitation applications.
• Rylon-1 Single-sided non-adherent wound dressing providing professional healthcare providers with advanced solutions for burn treatment and wound management.
• Silon-TSR Advanced wound care dressing used in burn centers, dermatology, and plastic surgery for superior wound management with non-adherent properties and demonstrated reduced nursing time per dressing change.
• Dual-Dress 50 Multi-layer foam dressing for effective management of graft site coverage, delivering 8.2 grams of water absorption per gram of foam with less than 20% swelling and consistent graft contact.
• Oleeva Fabric Silicone-based scar management product with fabric backing, designed for professional and consumer use in treating hypertrophic scars and keloids, including management of eyelid retraction and scar contracture.
• Oleeva Foam Foam-based scar management product offering silicone therapy for reduction and prevention of hypertrophic scars.
• Oleeva Scar Shapes Pre-shaped silicone scar management products designed to meet specific clinical needs for scar treatment across different anatomical areas.
• Oleeva Clear Clear silicone scar management product for discreet scar treatment applications.
• Silon-STS Silicone Thermoplastic Splinting product combining the moldability of thermoplastic splinting material with a therapeutic surface of silicone sheeting for facial scar treatment; custom formed over plaster molds for custom face masks with silicone durability exceeding other materials.
• Silon-LTS Low Temperature Splinting material combining the moldability of thermoplastic with therapeutic silicone sheeting for facial scar management, providing a cost-effective scar device that reduces contracture.
• Silon-TEX II OEKO-TEX Standard 100 Certified silicone-lined textile insert material sewn into pressure garments for hypertrophic scar and keloid management; durable, washable, and comfortable for patient use.
• Silon Gel Cleanser Gel cleanser product for use alongside Silon scar management products to support skin preparation and product care.
• SeaAllure Innovative nighttime skin-firming patch clinically proven to reduce the appearance of facial wrinkles, using moisturizing Silon polymer with silky fabric backing and sea-based skin-tightening ingredients; 80% of testers reported at least 25% improvement within 2 weeks. Sold directly to consumers via e-commerce and select spa locations.
• Suprathel Alloplastic, absorbable skin substitute for treatment of dermal wounds and burns including superficial, partial thickness, and deep partial thickness injuries; distributed exclusively in the U.S.A. by Bio Med Sciences.
• Contract R&D and Custom Manufacturing Services Custom design, development, and manufacturing services offered to medical device manufacturers, specializing in skin adhesive systems and thin film production at Bio Med's FDA-registered, ISO-compliant facility.

Quantifiable outcome

• Dual-Dress 50 maintains 8.2 grams water per gram of foam absorbency with less than 20% swelling
• +3 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered strategic, major, minor, regional and community.

• United States Army Institute of Surgical Research (USAISR)strategicStrategic or Co-development Partner · 1 February 2020Cooperative Research and Development Agreement (CRADA) to jointly develop a new antimicrobial wound dressing for battlefield deployment. USAISR contributes chemical formulation and antimicrobial testing expertise while Bio Med provides manufacturing knowhow and proprietary methods. Goal is to produce FDA cleared wound dressing over 3-year span.
• Pfizer Inc.majorOEM/ Whitelabel/ Licensing Partner · 1 January 2004Bio Med Sciences out-licensed Silon technology to Pfizer for consumer retail market. Pfizer launched Neosporin Scar Solution based on Bio Med's proprietary Silon technology, available at retail pharmacies. Bio Med continues to supply professional market under Oleeva brand while Pfizer handles retail distribution.
• Dr. DeneseminorOEM/ Whitelabel/ Licensing PartnerPartnership combining Silon technology with HydroShield for eye patch products. Products sold through QVC retail channel.
• Therapist Support Laboratory (TSL)regionalChannel Partner/ Reseller/ DistributorTSL appointed as exclusive authorized distributor for Bio Med products in Australia. TSL is a 100% Australian owned and managed family business chosen for its business values and commitment to burn care and rehabilitation.
• Physicians for PeacecommunityOthersNonprofit partnership for burn rehabilitation outreach in developing countries. Bio Med donates materials and clinical specialist expertise to support international burn care training missions.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Mölnlycke Health Care: Global wound care and scar therapy leader with Mepitel and Mepiform silicone-based scar products; competes head-to-head with Oleeva and Silon scar management lines.
• Smith & Nephew: Major advanced wound care company with Allevyn, Acticoat, and other burn/wound dressings; competes with Silon-TSR and exsalt T7 across burn centers and dermatology.
• ConvaTec: Wound and skin care player offering AQUACEL, DuoDERM and adjacent silicone-based dressings; competes with Bio Med's advanced wound care and scar therapy portfolio.
• Stratpharma: Specialist in silicone-based scar therapy (StrataDerm, Stratamed) and wound care products; directly comparable niche competitor in the medical-grade scar management category where Oleeva and Silon compete.
• Coloplast: Wound and skin care company offering Biatain, Comfeel and adjacent scar/wound products; competes in burn, dermatology, and post-surgical scar treatment markets.
• Integra LifeSciences: Regenerative wound care company (Integra Dermal Regeneration Template, PriMatrix) and skin substitute franchise; competes via Suprathel distributed by Bio Med and adjacent regenerative matrices.
• Organogenesis: Regenerative medicine company with Apligraf, NuShield, and other skin/wound biologics; competes in advanced wound care and skin substitute categories.
• BioCompression Systems / Scar Heal (ScarAway): Direct-to-consumer scar management brand using silicone sheet technology; competes with Oleeva and SeaAllure at the consumer OTC scar therapy shelf.

Emerging players

• MiMedx: Regenerative wound care company focused on amniotic membrane-based skin substitutes; overlaps with Bio Med's advanced wound care and Suprathel-distributed skin substitute lines.

Broad incumbents

• Solventum (formerly 3M Health Care): Broad medical device and wound care incumbent offering a wide portfolio of advanced wound dressings; competes with Bio Med across burn, dermatology, and surgical specialty channels as part of a much wider portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/watch?v=qt0SbereXgw
• Facebookfacebook.com/OleevaScarManagementSolutions
• Instagraminstagram.com/oleeva_scar_solutions
• LinkedInlinkedin.com/company/bio-med-sciences-inc-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bio Med Sciences